Published in Physician Law Weekly, January 4th, 2006
The rise in earnings was primarily attributable to increases in royalty income from Bausch & Lomb, derived from an exclusive worldwide license of one of the company's multifocal designs, coupled with strong demand for the company's C-Vue brand of multifocal and toric multifocal contact lens products.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.